Multivariate analysis of sociodemographic factors associated with CA-depression
| Characteristic . | OR . | 95% CI . |
|---|---|---|
| Sex | ||
| Male | Ref | |
| Female | 1.20 | 1.09-1.31 |
| Diagnosis | ||
| Lymphoma | Ref | |
| Myeloma | 1.36 | 1.22-1.52 |
| Leukemia | 1.08 | 0.94-1.24 |
| Myelodysplastic syndromes | 0.89 | 0.75-1.04 |
| Age (y) | ||
| 67-69 | Ref | |
| 70-74 | 1.06 | 0.90-1.25 |
| 75-79 | 1.02 | 0.87-1.20 |
| ≥80 | 1.10 | 0.94-1.28 |
| Marital status | ||
| Married | Ref | |
| Not married | 1.21 | 1.10-1.33 |
| Race | ||
| White | Ref | |
| Non-White | 0.80 | 0.69-0.93 |
| Education (census tract quintile)* | ||
| 1 (lowest) | Ref | |
| 2 | 0.87 | 0.76-1.00 |
| 3 | 0.88 | 0.76-1.01 |
| 4 | 0.89 | 0.77-1.04 |
| 5 (highest) | 0.84 | 0.71-0.98 |
| Median income (census tract quintile)† | ||
| 1 (lowest) | Ref | |
| 2 | 1.00 | 0.87-1.15 |
| 3 | 0.92 | 0.79-1.06 |
| 4 | 0.98 | 0.84-1.13 |
| 5 (highest) | 0.94 | 0.81-1.09 |
| Surveillance, Epidemiology, and End Results registry region | ||
| Midwest | Ref | |
| Northeast | 0.64 | 0.55-0.75 |
| South | 0.76 | 0.66-0.88 |
| West | 0.79 | 0.69-0.90 |
| Charlson comorbidity score | ||
| 0 | Ref | |
| 1 | 1.21 | 1.09-1.35 |
| 2+ | 1.54 | 1.39-1.71 |
| Precancer anxiety | ||
| Absent | Ref | |
| Present | 2.98 | 2.61-3.41 |
| Characteristic . | OR . | 95% CI . |
|---|---|---|
| Sex | ||
| Male | Ref | |
| Female | 1.20 | 1.09-1.31 |
| Diagnosis | ||
| Lymphoma | Ref | |
| Myeloma | 1.36 | 1.22-1.52 |
| Leukemia | 1.08 | 0.94-1.24 |
| Myelodysplastic syndromes | 0.89 | 0.75-1.04 |
| Age (y) | ||
| 67-69 | Ref | |
| 70-74 | 1.06 | 0.90-1.25 |
| 75-79 | 1.02 | 0.87-1.20 |
| ≥80 | 1.10 | 0.94-1.28 |
| Marital status | ||
| Married | Ref | |
| Not married | 1.21 | 1.10-1.33 |
| Race | ||
| White | Ref | |
| Non-White | 0.80 | 0.69-0.93 |
| Education (census tract quintile)* | ||
| 1 (lowest) | Ref | |
| 2 | 0.87 | 0.76-1.00 |
| 3 | 0.88 | 0.76-1.01 |
| 4 | 0.89 | 0.77-1.04 |
| 5 (highest) | 0.84 | 0.71-0.98 |
| Median income (census tract quintile)† | ||
| 1 (lowest) | Ref | |
| 2 | 1.00 | 0.87-1.15 |
| 3 | 0.92 | 0.79-1.06 |
| 4 | 0.98 | 0.84-1.13 |
| 5 (highest) | 0.94 | 0.81-1.09 |
| Surveillance, Epidemiology, and End Results registry region | ||
| Midwest | Ref | |
| Northeast | 0.64 | 0.55-0.75 |
| South | 0.76 | 0.66-0.88 |
| West | 0.79 | 0.69-0.90 |
| Charlson comorbidity score | ||
| 0 | Ref | |
| 1 | 1.21 | 1.09-1.35 |
| 2+ | 1.54 | 1.39-1.71 |
| Precancer anxiety | ||
| Absent | Ref | |
| Present | 2.98 | 2.61-3.41 |
See Table 1 footnotes.